WallStreetZenWallStreetZen

NASDAQ: HOTH
Hoth Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HOTH

Based on 1 analyst offering 12 month price targets for Hoth Therapeutics Inc

Min Forecast
$5.00+624.64%
Avg Forecast
$5.00+624.64%
Max Forecast
$5.00+624.64%

Should I buy or sell HOTH stock?

Based on 1 analyst offering ratings for Hoth Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HOTH's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HOTH as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their HOTH stock forecasts and price targets.

HOTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-25

1 of 1

Forecast return on equity

Is HOTH forecast to generate an efficient return?

Company
N/A
Industry
85.8%
Market
169.74%

Forecast return on assets

Is HOTH forecast to generate an efficient return on assets?

Company
N/A
Industry
29.42%

HOTH earnings per share forecast

What is HOTH's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.60
Avg 2 year Forecast
-$0.71
Avg 3 year Forecast
-$1.21

HOTH revenue forecast

What is HOTH's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

HOTH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HOTH$0.64$5.00+681.25%Strong Buy
CVM$1.45N/AN/A
KPRX$2.68N/AN/A
KAPA$0.55N/AN/A
PHIO$1.09$14.00+1,184.40%Buy
View Top Biotech Stocks

Hoth Therapeutics Stock Forecast FAQ

Is Hoth Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HOTH) stock is to Strong Buy HOTH stock.

Out of 1 analyst, 1 (100%) are recommending HOTH as a Strong Buy, 0 (0%) are recommending HOTH as a Buy, 0 (0%) are recommending HOTH as a Hold, 0 (0%) are recommending HOTH as a Sell, and 0 (0%) are recommending HOTH as a Strong Sell.

If you're new to stock investing, here's how to buy Hoth Therapeutics stock.

What is HOTH's earnings growth forecast for 2026-2028?

(NASDAQ: HOTH) Hoth Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.38%.

Hoth Therapeutics's earnings in 2026 is -$11,685,931.On average, 3 Wall Street analysts forecast HOTH's earnings for 2026 to be -$11,511,016, with the lowest HOTH earnings forecast at -$11,059,603, and the highest HOTH earnings forecast at -$11,849,575. On average, 3 Wall Street analysts forecast HOTH's earnings for 2027 to be -$13,657,137, with the lowest HOTH earnings forecast at -$13,121,563, and the highest HOTH earnings forecast at -$14,058,818.

In 2028, HOTH is forecast to generate -$23,217,133 in earnings, with the lowest earnings forecast at -$22,306,657 and the highest earnings forecast at -$23,899,990.

What is HOTH's revenue growth forecast for 2026-2028?

(NASDAQ: HOTH) Hoth Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Hoth Therapeutics's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast HOTH's revenue for 2026 to be $0, with the lowest HOTH revenue forecast at $0, and the highest HOTH revenue forecast at $0. On average, 3 Wall Street analysts forecast HOTH's revenue for 2027 to be $0, with the lowest HOTH revenue forecast at $0, and the highest HOTH revenue forecast at $0.

In 2028, HOTH is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is HOTH's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: HOTH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 29.42%.

What is HOTH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HOTH price target, the average HOTH price target is $5.00, with the highest HOTH stock price forecast at $5.00 and the lowest HOTH stock price forecast at $5.00.

The Wall Street analyst predicted that Hoth Therapeutics's share price could reach $5.00 by Mar 25, 2027. The average Hoth Therapeutics stock price prediction forecasts a potential upside of 681.25% from the current HOTH share price of $0.64.

What is HOTH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: HOTH) Hoth Therapeutics's current Earnings Per Share (EPS) is -$0.80. On average, analysts forecast that HOTH's EPS will be -$0.60 for 2026, with the lowest EPS forecast at -$0.58, and the highest EPS forecast at -$0.62. On average, analysts forecast that HOTH's EPS will be -$0.71 for 2027, with the lowest EPS forecast at -$0.69, and the highest EPS forecast at -$0.74. In 2028, HOTH's EPS is forecast to hit -$1.21 (min: -$1.17, max: -$1.25).

What is HOTH's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: HOTH) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.